Kodak Stock Lawsuit Investigation

In July of 2020, Eastman Kodak announced that it had received a $765 million loan from the government to produce drug ingredients related to COVID-19. Barron’s reports that Kodak’s surprise announcement resulted in a 1,167% increase in KODK’s stock price within two days. The stock was briefly trading at $60 per share on July 29th, but is now trading as low as $10 on August 10th, the article states.

According to CNBC, the Securities and Exchange Commission has opened up an investigation into the way the company disclosed the government deal, as well as “stock options that were granted to executive chairman James Continenza ahead of the announcement.”

Then, on August 7th, the DFC tweeted,

On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of wrongdoing raise serious concerns. We will not proceed any further unless these allegations are cleared.

On this news, Eastman Kodak stock dropped nearly 30% in intraday trading. If you lost money in Kodak stock, you may have a claim. Speak with a securities lawyer to learn more about your options.

Our securities lawyers have recovered over a billion dollars on behalf of our clients against behemoths, such as Chase Bank, Mastercard, and Anthem Blue Cross Blue Shield. Read more about our results.

You “shouldn’t presume that powerful banks and other powerful interests can just get away with doing bad things. Good, qualified counsel that are committed to a cause can usually figure out how to prosecute such cases effectively and prevail.”

–Eric Gibbs, award-winning securities attorney

Praise from the Courts

Federal judge in our AT&T class action:

“I’ve always found them to be extraordinary counsel in terms of their preparation and their professionalism.”

Federal judge in our Chase lawsuit (resulting in $100 million settlement):

They “fought tooth and nail, down to the wire” to achieve “the best settlement that they could under the circumstances.”

Read more about what judges say about us.